$2.95
-0.04 (-1.34%)
Open$3.02
Previous Close$2.99
Day High$3.08
Day Low$2.82
52W High$7.33
52W Low$2.05
Volume—
Avg Volume2.04M
Market Cap47.35M
P/E Ratio—
EPS$-0.78
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,170.5% upside
Current
$2.95
$2.95
Target
$37.48
$37.48
$21.76
$37.48 avg
$51.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 20.10M | 30.88M | 6.59M |
| Net Income | -44,984,285 | -62,209,367 | 1.64M |
| Profit Margin | -223.9% | -212.7% | 24.9% |
| EBITDA | -43,610,376 | -63,659,891 | 3.19M |
| Free Cash Flow | — | — | 1.30M |
| Rev Growth | -34.9% | -34.9% | +19.2% |
| Debt/Equity | — | — | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |